Qualitative interaction trees: a tool to identify qualitative treatment–subgroup interactions
Abstract
When two alternative treatments (A and B) are available, some subgroup of patients may display a better outcome with treatment A than with B, whereas for another subgroup, the reverse may be true. If this is the case, a qualitative (i.e., disordinal) treatment–subgroup interaction is present. Such interactions imply that some subgroups of patients should be treated differently and are therefore most relevant for personalized medicine. In case of data from randomized clinical trials with many patient characteristics that could interact with treatment in a complex way, a suitable statistical approach to detect qualitative treatment–subgroup interactions is not yet available. As a way out, in the present paper, we propose a new method for this purpose, called QUalitative INteraction Trees (QUINT). QUINT results in a binary tree that subdivides the patients into terminal nodes on the basis of patient characteristics; these nodes are further assigned to one of three classes: a first for which A is better than B, a second for which B is better than A, and an optional third for which type of treatment makes no difference. Results of QUINT on simulated data showed satisfactory performance, with regard to optimization and recovery. Results of an application to real data suggested that, compared with other approaches, QUINT provided a more pronounced picture of the qualitative interactions that are present in the data. Copyright © 2013 John Wiley & Sons, Ltd.
Citing Literature
Number of times cited according to CrossRef: 59
- Lei Shen, Hollins Showalter, Chakib Battioui, Brian Denton, Subgroup Identification for Tailored Therapies: Methods and Consistent Evaluation, Design and Analysis of Subgroups with Biopharmaceutical Applications, 10.1007/978-3-030-40105-4_8, (181-197), (2020).
- Jia Jia, Qi Tang, Wangang Xie, A Novel Method of Subgroup Identification by Combining Virtual Twins with GUIDE (VG) for Development of Precision Medicines, Design and Analysis of Subgroups with Biopharmaceutical Applications, 10.1007/978-3-030-40105-4_7, (167-180), (2020).
- Yang Liu, Lijiang Geng, Xiaojing Wang, Donghui Zhang, Ming-Hui Chen, Subgroup Analysis from Bayesian Perspectives, Design and Analysis of Subgroups with Biopharmaceutical Applications, 10.1007/978-3-030-40105-4_16, (331-345), (2020).
- Alex Dmitrienko, Ilya Lipkovich, Aaron Dane, Christoph Muysers, Data-Driven and Confirmatory Subgroup Analysis in Clinical Trials, Design and Analysis of Subgroups with Biopharmaceutical Applications, 10.1007/978-3-030-40105-4_3, (33-91), (2020).
- Megan Shepherd-Banigan, Valerie A. Smith, Jennifer H. Lindquist, Michael Paul Cary, Katherine E. M. Miller, Jennifer G. Chapman, Courtney H. Van Houtven, Identifying treatment effects of an informal caregiver education intervention to increase days in the community and decrease caregiver distress: a machine-learning secondary analysis of subgroup effects in the HI-FIVES randomized clinical trial, Trials, 10.1186/s13063-020-4113-x, 21, 1, (2020).
- Victoria Chen, Heping Zhang, Depth Importance in Precision Medicine (DIPM): A Tree and Forest Based Method, Contemporary Experimental Design, Multivariate Analysis and Data Mining, 10.1007/978-3-030-46161-4, (243-259), (2020).
- Joeke van Santen, Rose-Marie Dröes, Jos W.R. Twisk, Olivier A. Blanson Henkemans, Annemieke van Straten, Franka J.M. Meiland, Effects of Exergaming on Cognitive and Social Functioning of People with Dementia: A Randomized Controlled Trial, Journal of the American Medical Directors Association, 10.1016/j.jamda.2020.04.018, (2020).
- Kazushi Maruo, Toshi A. Furukawa, Hisashi Noma, Hissei Imai, Kazutaka Ikeda, Shigeto Yamawaki, Qualitative treatment-subgroup interactions in the antidepressant treatment of major depression: Application of QUINT to individual participant data from seven placebo-controlled randomized controlled trials, Personalized Medicine in Psychiatry, 10.1016/j.pmip.2019.100054, (100054), (2020).
- Ilya Lipkovich, Bohdana Ratitch, Cristina Ivanescu, Statistical Data Mining of Clinical Data, Quantitative Methods in Pharmaceutical Research and Development, 10.1007/978-3-030-48555-9, (225-315), (2020).
- Julia Krzykalla, Axel Benner, Annette Kopp‐Schneider, Exploratory identification of predictive biomarkers in randomized trials with normal endpoints, Statistics in Medicine, 10.1002/sim.8452, 39, 7, (923-939), (2019).
- Maren K. Olsen, Karen M. Stechuchak, Karen E. Steinhauser, Comparing internal and external validation in the discovery of qualitative treatment-subgroup effects using two small clinical trials, Contemporary Clinical Trials Communications, 10.1016/j.conctc.2019.100372, (100372), (2019).
- Marleen J. ter Avest, Elise Dusseldorp, Marloes J. Huijbers, Joël R. van Aalderen, Mira B. Cladder-Micus, Philip Spinhoven, Corina U. Greven, Anne E.M. Speckens, Added value of Mindfulness-Based Cognitive Therapy for depression: A tree-based qualitative interaction analysis, Behaviour Research and Therapy, 10.1016/j.brat.2019.103467, (103467), (2019).
- Aniek Sies, Iven Van Mechelen, Estimating the quality of optimal treatment regimes, Statistics in Medicine, 10.1002/sim.8342, 38, 25, (4925-4938), (2019).
- Oleg Sysoev, Krzysztof Bartoszek, Eva‐Charlotte Ekström, Katarina Ekholm Selling, PSICA: Decision trees for probabilistic subgroup identification with categorical treatments, Statistics in Medicine, 10.1002/sim.8308, 38, 22, (4436-4452), (2019).
- Jialiang Li, Mu Yue, Wenyang Zhang, Subgroup identification via homogeneity pursuit for dense longitudinal/spatial data, Statistics in Medicine, 10.1002/sim.8192, 38, 17, (3256-3271), (2019).
- Xin Qiu, Yuanjia Wang, Composite interaction tree for simultaneous learning of optimal individualized treatment rules and subgroups, Statistics in Medicine, 10.1002/sim.8105, 38, 14, (2632-2651), (2019).
- M. Man, T. S. Nguyen, C. Battioui, G. Mi, Predictive Subgroup/Biomarker Identification and Machine Learning Methods, Statistical Methods in Biomarker and Early Clinical Development, 10.1007/978-3-030-31503-0, (1-22), (2019).
- Peng Wu, Tianchen Xu, Yuanjia Wang, undefined, 2019 IEEE International Conference on Data Science and Advanced Analytics (DSAA), 10.1109/DSAA.2019.00054, (392-402), (2019).
- Joeke van Santen, Rose-Marie Dröes, Judith E. Bosmans, Olivier A. Blanson Henkemans, Sjef van Bommel, Esther Hakvoort, Ronald Valk, Carla Scholten, Joris Wiersinga, Annemieke van Straten, Franka Meiland, The (cost-) effectiveness of exergaming in people living with dementia and their informal caregivers: protocol for a randomized controlled trial, BMC Geriatrics, 10.1186/s12877-019-1062-x, 19, 1, (2019).
- Sanne van Luenen, Vivian Kraaij, Philip Spinhoven, Elise Dusseldorp, Nadia Garnefski, Moderators of the effect of guided online self-help for people with HIV and depressive symptoms, AIDS Care, 10.1080/09540121.2019.1679703, (1-7), (2019).
- Lin Taft, Changyu Shen, A non-parametric statistical test of null treatment effect in sub-populations, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2019.1636810, (1-17), (2019).
- Yang Liu, Xiwen Ma, Donghui Zhang, Lijiang Geng, Xiaojing Wang, Wei Zheng, Ming-Hui Chen, Look before you leap: systematic evaluation of tree-based statistical methods in subgroup identification, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2019.1584204, (1-21), (2019).
- Aniek Sies, Koen Demyttenaere, Iven Van Mechelen, Studying treatment-effect heterogeneity in precision medicine through induced subgroups, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2019.1579220, (1-17), (2019).
- Wei‐Yin Loh, Michael Man, Shuaicheng Wang, Subgroups from regression trees with adjustment for prognostic effects and postselection inference, Statistics in Medicine, 10.1002/sim.7677, 38, 4, (545-557), (2018).
- Xiaogang Su, Annette T. Peña, Lei Liu, Richard A. Levine, Random forests of interaction trees for estimating individualized treatment effects in randomized trials, Statistics in Medicine, 10.1002/sim.7660, 37, 17, (2547-2560), (2018).
- Dipesh Mistry, Nigel Stallard, Martin Underwood, A recursive partitioning approach for subgroup identification in individual patient data meta‐analysis, Statistics in Medicine, 10.1002/sim.7609, 37, 9, (1550-1561), (2018).
- Marius Thomas, Björn Bornkamp, Heidi Seibold, Subgroup identification in dose‐finding trials via model‐based recursive partitioning, Statistics in Medicine, 10.1002/sim.7594, 37, 10, (1608-1624), (2018).
- Richard C. Zink, Detecting Safety Signals Among Adverse Events in Clinical Trials, Biopharmaceutical Applied Statistics Symposium, 10.1007/978-981-10-7826-2_7, (107-125), (2018).
- Parvin Tajik, Mohammad Hadi Zafarmand, Aeilko H. Zwinderman, Ben W. Mol, Patrick M. Bossuyt, Development and evaluating multimarker models for guiding treatment decisions, BMC Medical Informatics and Decision Making, 10.1186/s12911-018-0619-5, 18, 1, (2018).
- D. A. C. Oprel, C. M. Hoeboer, M. Schoorl, R. A. De Kleine, I. G. Wigard, M. Cloitre, A. Van Minnen, W. Van der Does, Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment, BMC Psychiatry, 10.1186/s12888-018-1967-5, 18, 1, (2018).
- Igor Kulev, Pearl Pu, Boi Faltings, A Bayesian Approach to Intervention-Based Clustering, ACM Transactions on Intelligent Systems and Technology, 10.1145/3156683, 9, 4, (1-23), (2018).
- Alexander Hapfelmeier, Kurt Ulm, Bernhard Haller, Subgroup identification by recursive segmentation, Journal of Applied Statistics, 10.1080/02664763.2018.1444152, (1-24), (2018).
- Kevin Doubleday, Hua Zhou, Haoda Fu, Jin Zhou, An Algorithm for Generating Individualized Treatment Decision Trees and Random Forests, Journal of Computational and Graphical Statistics, 10.1080/10618600.2018.1451337, (1-12), (2018).
- M. Fokkema, N. Smits, A. Zeileis, T. Hothorn, H. Kelderman, Detecting treatment-subgroup interactions in clustered data with generalized linear mixed-effects model trees, Behavior Research Methods, 10.3758/s13428-017-0971-x, 50, 5, (2016-2034), (2017).
- Heidi Seibold, Achim Zeileis, Torsten Hothorn, Individual treatment effect prediction for amyotrophic lateral sclerosis patients, Statistical Methods in Medical Research, 10.1177/0962280217693034, 27, 10, (3104-3125), (2017).
- Richard C. Zink, Olga Marchenko, Matilde Sanchez-Kam, Haijun Ma, Qi Jiang, Sources of Safety Data and Statistical Strategies for Design and Analysis, Therapeutic Innovation & Regulatory Science, 10.1177/2168479017738980, 52, 2, (141-158), (2017).
- Milad Zafar Nezhad, Dongxiao Zhu, Najibesadat Sadati, Kai Yang, Phillip Levi, undefined, 2017 16th IEEE International Conference on Machine Learning and Applications (ICMLA), 10.1109/ICMLA.2017.00-68, (755-760), (2017).
- Aniek Sies, Iven Van Mechelen, Comparing Four Methods for Estimating Tree-Based Treatment Regimes, The International Journal of Biostatistics, 10.1515/ijb-2016-0068, 13, 1, (2017).
- Miguel A. García-Pérez, Thou Shalt Not Bear False Witness Against Null Hypothesis Significance Testing, Educational and Psychological Measurement, 10.1177/0013164416668232, 77, 4, (631-662), (2016).
- Ilya Lipkovich, Alex Dmitrienko, Ralph B., Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials, Statistics in Medicine, 10.1002/sim.7064, 36, 1, (136-196), (2016).
- Madhukar H. Trivedi, Patrick J. McGrath, Maurizio Fava, Ramin V. Parsey, Benji T. Kurian, Mary L. Phillips, Maria A. Oquendo, Gerard Bruder, Diego Pizzagalli, Marisa Toups, Crystal Cooper, Phil Adams, Sarah Weyandt, David W. Morris, Bruce D. Grannemann, R. Todd Ogden, Randy Buckner, Melvin McInnis, Helena C. Kraemer, Eva Petkova, Thomas J. Carmody, Myrna M. Weissman, Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design, Journal of Psychiatric Research, 10.1016/j.jpsychires.2016.03.001, 78, (11-23), (2016).
- Margriet A. G. Formanoy, Elise Dusseldorp, Jennifer K. Coffeng, Iven Van Mechelen, Cecile R. L. Boot, Ingrid J. M. Hendriksen, Erwin C. P. M. Tak, Physical activity and relaxation in the work setting to reduce the need for recovery: what works for whom?, BMC Public Health, 10.1186/s12889-016-3457-3, 16, 1, (2016).
- E. Driessen, N. Smits, J. J. M. Dekker, J. Peen, F. J. Don, S. Kool, D. Westra, M. Hendriksen, P. Cuijpers, H. L. Van, Differential efficacy of cognitive behavioral therapy and psychodynamic therapy for major depression: a study of prescriptive factors, Psychological Medicine, 10.1017/S0033291715001853, 46, 4, (731-744), (2016).
- Wei‐Yin Loh, Haoda Fu, Michael Man, Victoria Champion, Menggang Yu, Identification of subgroups with differential treatment effects for longitudinal and multiresponse variables, Statistics in Medicine, 10.1002/sim.7020, 35, 26, (4837-4855), (2016).
- Xiwen Ma, Wei Zheng, Yuefeng Lu, Personalized Effective Dose Selection in Dose Ranging Studies, Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics, 10.1007/978-3-319-42568-9_8, (91-104), (2016).
- Bianca E. Boyer, Lisa L. Doove, Hilde M. Geurts, Pier J. M. Prins, Iven Van Mechelen, Saskia Van der Oord, Qualitative Treatment-Subgroup Interactions in a Randomized Clinical Trial of Treatments for Adolescents with ADHD: Exploring What Cognitive-Behavioral Treatment Works for Whom, PLOS ONE, 10.1371/journal.pone.0150698, 11, 3, (e0150698), (2016).
- Lisa L. Doove, Katrijn Van Deun, Elise Dusseldorp, Iven Van Mechelen, QUINT: A tool to detect qualitative treatment–subgroup interactions in randomized controlled trials, Psychotherapy Research, 10.1080/10503307.2015.1062934, 26, 5, (612-622), (2015).
- Elise Dusseldorp, Lisa Doove, Iven van Mechelen, Quint: An R package for the identification of subgroups of clients who differ in which treatment alternative is best for them, Behavior Research Methods, 10.3758/s13428-015-0594-z, 48, 2, (650-663), (2015).
- Thomas Ondra, Alex Dmitrienko, Tim Friede, Alexandra Graf, Frank Miller, Nigel Stallard, Martin Posch, Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2015.1092034, 26, 1, (99-119), (2015).
- Richard C. Zink, Lei Shen, Russell D. Wolfinger, H.D. Hollins Showalter, Assessment of Methods to Identify Patient Subgroups with Enhanced Treatment Response in Randomized Clinical Trials, Applied Statistics in Biomedicine and Clinical Trials Design, 10.1007/978-3-319-12694-4_24, (395-410), (2015).
- Yaoyao Xu, Menggang Yu, Ying‐Qi Zhao, Quefeng Li, Sijian Wang, Jun Shao, Regularized outcome weighted subgroup identification for differential treatment effects, Biometrics, 10.1111/biom.12322, 71, 3, (645-653), (2015).
- Ralitza Gueorguieva, Ran Wu, Wan-Min Tsai, Patrick G. O’Connor, Lisa Fucito, Heping Zhang, Stephanie S. O’Malley, An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate, European Neuropsychopharmacology, 10.1016/j.euroneuro.2015.06.006, 25, 10, (1586-1599), (2015).
- Stephen J. Ruberg, Lei Shen, Personalized Medicine: Four Perspectives of Tailored Medicine, Statistics in Biopharmaceutical Research, 10.1080/19466315.2015.1059354, 7, 3, (214-229), (2015).
- Lei Shen, Ying Ding, Chakib Battioui, A Framework of Statistical Methods for Identification of Subgroups with Differential Treatment Effects in Randomized Trials, Applied Statistics in Biomedicine and Clinical Trials Design, 10.1007/978-3-319-12694-4_25, (411-425), (2015).
- Alex Dmitrienko, Ilya Lipkovich, Alan Hopkins, Yu-Ping Li, Whedy Wang, Biomarker Evaluation and Subgroup Identification in a Pneumonia Development Program Using SIDES, Applied Statistics in Biomedicine and Clinical Trials Design, 10.1007/978-3-319-12694-4_26, (427-466), (2015).
- Stuart G Baker, Barnett S Kramer, Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themes, Clinical Trials, 10.1177/1740774514557725, 12, 4, (299-308), (2015).
- Wei‐Yin Loh, Xu He, Michael Man, A regression tree approach to identifying subgroups with differential treatment effects, Statistics in Medicine, 10.1002/sim.6454, 34, 11, (1818-1833), (2015).
- Wei‐Yin Loh, Rejoinder, International Statistical Review, 10.1111/insr.12057, 82, 3, (367-370), (2014).
- Pingye Zhang, Junshui Ma, Xinqun Chen, Yue Shentu, A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival data, Statistics in Medicine, 10.1002/sim.8714, 0, 0, (undefined).




